Phase II Clinical Study of Befotertinib in EGFR Non-classical Mutant NSCLC

Lead

Second Affiliated Hospital, Zhejiang University, School of Medicine

With

• Zhengzhou University
• Hunan Cancer Hospital - the Affiliated Cancer Hospital of Xiangya school of Medicine, Central South University
• Taizhou Hospital
• West China Hospital